206 related articles for article (PubMed ID: 27251446)
1. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
Wang S; Yuan L
Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
[TBL] [Abstract][Full Text] [Related]
2. Update on Biomarkers in Development of Anti-angiogenic Drugs in Gastric Cancer.
Jia S; Cai J
Anticancer Res; 2016 Mar; 36(3):1111-8. PubMed ID: 26977006
[TBL] [Abstract][Full Text] [Related]
3. Drug sensitivity testing platforms for gastric cancer diagnostics.
Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
[TBL] [Abstract][Full Text] [Related]
4. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
[TBL] [Abstract][Full Text] [Related]
5. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
Beeharry MK; Liu WT; Yan M; Zhu ZG
World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
[TBL] [Abstract][Full Text] [Related]
6. Recent updates of precision therapy for gastric cancer: Towards optimal tailored management.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2016 May; 22(19):4638-50. PubMed ID: 27217696
[TBL] [Abstract][Full Text] [Related]
7. Review of recent molecular landscape knowledge of gastric cancer.
Shimizu D; Kanda M; Kodera Y
Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in gastric cancer early diagnosis.
Necula L; Matei L; Dragu D; Neagu AI; Mambet C; Nedeianu S; Bleotu C; Diaconu CC; Chivu-Economescu M
World J Gastroenterol; 2019 May; 25(17):2029-2044. PubMed ID: 31114131
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
Matuszcak C; Haier J; Hummel R; Lindner K
World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
[TBL] [Abstract][Full Text] [Related]
11. Emerging molecular basis of hematogenous metastasis in gastric cancer.
Zhong J; Chen Y; Wang LJ
World J Gastroenterol; 2016 Feb; 22(8):2434-40. PubMed ID: 26937132
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenomics of the first-line treatment for gastric cancer: advances in the identification of genomic biomarkers for clinical response to chemotherapy].
Castro-Rojas C; Ortiz-Lópezj R; Rojas-Martínez A
Invest Clin; 2014 Jun; 55(2):185-202. PubMed ID: 24974634
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
De Mattia E; Cecchin E; Toffoli G
Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
[TBL] [Abstract][Full Text] [Related]
15. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
16. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine.
Xu W; Beeharry MK; Liu W; Yan M; Zhu Z
Biomed Res Int; 2016; 2016():3923585. PubMed ID: 28105420
[TBL] [Abstract][Full Text] [Related]
18. Personalized treatment for patients with colorectal cancer: role of biomarkers.
Duffy MJ
Biomark Med; 2015; 9(4):337-47. PubMed ID: 25808438
[TBL] [Abstract][Full Text] [Related]
19. Transcription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.
Sun J; Du N; Li J; Zhou J; Tao G; Sun S; He J
Technol Cancer Res Treat; 2016 Apr; 15(2):285-95. PubMed ID: 25810491
[TBL] [Abstract][Full Text] [Related]
20. Proteomic and metabolic prediction of response to therapy in gastric cancer.
Aichler M; Luber B; Lordick F; Walch A
World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
